To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HMBSTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
421 supporting clones for gene HMBS back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM470973 leiomyosarcoma, uterus .a 1 to 861 9 to 874       874/1051
(83 %)
20 diff
(98.1 %id)
NM_000190.3   .a 1 to 1501 9 to 1509 exact RefSeq, AAA   1509/1509
(100 %)
0 diff
(100 %id)
AW245832 lung, small cell carcinoma .a 1 to 559 12 to 570       566/570
(99 %)
6 diff
(99.0 %id)
AK290275 colon .a 1 to 1499 5 to 1503 exact     1503/1503
(100 %)
0 diff
(100 %id)
DB455453 testis .a 1 to 455 5 to 459       459/459
(100 %)
1 diff
(99.8 %id)
AU105500   .a 1 to 46 5 to 50       50/50
(100 %)
0 diff
(100 %id)
BP256811 Kidney .a 1 to 578 5 to 582       582/582
(100 %)
0 diff
(100 %id)
CB124380 Liver .a 1 to 545 5 to 549       549/549
(100 %)
1 diff
(99.9 %id)
BM786612 Ascites, stomach .a 1 to 545 5 to 550       550/550
(100 %)
6 diff
(99.0 %id)
TI_1540412882   .a 1 to 273 280 to 2       275/314
(87 %)
9 diff
(97.2 %id)
AK310343 testis .a 1 to 1036 4 to 1384       993/1384
(71 %)
11 diff
(99.3 %id)
BP210213 cerebellum .a 1 to 575 4 to 578       578/578
(100 %)
1 diff
(99.9 %id)
DA430772 colon .a 1 to 552 5 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BP332107 renal proximal tubule .a 1 to 579 4 to 581       581/582
(99 %)
23 diff
(96.1 %id)
BM838775 Ascites, stomach .a 1 to 530 4 to 531       531/531
(100 %)
3 diff
(99.5 %id)
DC399834 testis .a 1 to 539 4 to 543       543/543
(100 %)
2 diff
(99.7 %id)
BC000520 Lung, small cell carcinoma .a 1 to 1499 3 to 1501 exact available from MGC, AAA   1501/1501
(100 %)
1 diff
(100.0 %id)
BC019323 Lung, small cell carcinoma .a 1 to 1499 3 to 1501 exact tiling clone, available from MGC, AAA   1501/1501
(100 %)
0 diff
(100 %id)
AA099935 colon, tumor .a 1 to 409 2 to 407       407/407
(100 %)
12 diff
(97.1 %id)
AU105503   .a 1 to 49 1 to 50       50/50
(100 %)
2 diff
(96.0 %id)
BP283699 bone marrow .a 1 to 587 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
CB111144 Liver .a 1 to 532 1 to 532       532/532
(100 %)
0 diff
(100 %id)
CB135842 Liver .a 1 to 382 1 to 382       382/382
(100 %)
3 diff
(99.3 %id)
BP290170 lung .a 1 to 499 1 to 501       501/580
(86 %)
9 diff
(98.5 %id)
BM786252 Ascites, stomach .a 1 to 596 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
BP245492 Kidney .a 2 to 589 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
CB111504 Liver .a 2 to 638 1 to 637       637/637
(100 %)
2 diff
(99.7 %id)
CR613896 T cells (Jurkat cell line) .a 3 to 1457 1 to 1455 exact     1455/1455
(100 %)
0 diff
(100 %id)
AL557370 T cells (Jurkat cell line), T cells from T cell leukemia .a 3 to 678 1 to 677   fully sequenced,   677/677
(100 %)
2 diff
(99.8 %id)
D28419 lymphoma .a 4 to 155 1 to 152       152/152
(100 %)
1 diff
(99.4 %id)
BP254824 Kidney .a 6 to 564 8 to 566       559/566
(98 %)
8 diff
(98.6 %id)
BU600397 mixed (pool of 40 RNAs) .a 6 to 647 1 to 650       648/809
(80 %)
12 diff
(98.6 %id)
CB113952 Liver .a 6 to 460 1 to 455       455/455
(100 %)
4 diff
(99.2 %id)
AU143511   .a 7 to 769 2 to 760   capped   759/806
(94 %)
9 diff
(98.9 %id)
TI_57175920   .a 8 to 801 58 to 850       793/854
(92 %)
14 diff
(98.4 %id)
BM718402 eye, fetal eye .a 8 to 550 1 to 543       543/543
(100 %)
0 diff
(100 %id)
CB112277 Liver .a 9 to 550 1 to 542       542/542
(100 %)
0 diff
(100 %id)
CN343427 embryonic stem cells, DMSO-treated H9 cellline .a 13 to 743 1 to 731       731/731
(100 %)
4 diff
(99.5 %id)
CN343430 embryonic stem cells, DMSO-treated H9 cellline .a 13 to 489 1 to 477       477/477
(100 %)
1 diff
(99.8 %id)
CR612613 Neuroblastoma Cot 10-normalized .a 13 to 1486 1 to 1474 exact     1474/1474
(100 %)
0 diff
(100 %id)
CR621119 Placenta Cot 25-normalized .a 13 to 1467 1 to 1455 exact     1455/1455
(100 %)
0 diff
(100 %id)
AL520285 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 13 to 678 1 to 665   fully sequenced,   665/665
(100 %)
2 diff
(99.7 %id)
BX358897 Placenta Cot 25-normalized .a 13 to 678 1 to 664   fully sequenced,   664/664
(100 %)
3 diff
(99.6 %id)
BG336990 leiomyosarcoma cell line, uterus .a 13 to 746 1 to 731       731/873
(83 %)
13 diff
(98.6 %id)
BG324732 Kidney, renal cell adenocarcinoma .a 13 to 443 1 to 451       405/453
(89 %)
19 diff
(95.9 %id)
BI829566 brain, medulla .a 13 to 801 1 to 788       788/792
(99 %)
9 diff
(98.9 %id)
BI912647 leukocyte .a 13 to 757 28 to 773       746/788
(94 %)
10 diff
(98.8 %id)
BM047977 carcinoma, cell line, Prostate .a 13 to 768 1 to 762       705/774
(91 %)
42 diff
(94.6 %id)
BM047809 carcinoma, cell line, Prostate .a 13 to 919 1 to 911       911/911
(100 %)
22 diff
(97.6 %id)
BM906278 ovary (pool of 3) .a 13 to 758 13 to 757       745/1126
(66 %)
15 diff
(98.7 %id)
BQ072958 leukocyte .a 13 to 580 69 to 638       570/1225
(46 %)
19 diff
(98.5 %id)
TI_57197101   .a 13 to 784 53 to 823       771/823
(93 %)
8 diff
(99.1 %id)
TI_57247404   .a 13 to 757 28 to 773       746/788
(94 %)
10 diff
(98.8 %id)
BF204322 muscle, rhabdomyosarcoma .a 14 to 675 1 to 657       657/658
(99 %)
6 diff
(99.1 %id)
BF971877 leiomyosarcoma cell line, uterus .a 14 to 883 1 to 867       867/970
(89 %)
28 diff
(97.2 %id)
BG329901 eye, retinoblastoma .a 14 to 624 1 to 610       610/611
(99 %)
14 diff
(97.8 %id)
BI114662 muscle, rhabdomyosarcoma .a 14 to 743 1 to 729       729/733
(99 %)
4 diff
(99.5 %id)
BI820915 pooled brain, lung, testis .a 14 to 784 1 to 770       770/770
(100 %)
3 diff
(99.7 %id)
BQ062654 lymph, lymphoma, cell line .a 14 to 974 1 to 969       967/1044
(92 %)
25 diff
(97.7 %id)
BU502480 carcinoma, cell line, Prostate .a 14 to 758 28 to 776       747/963
(77 %)
12 diff
(98.8 %id)
BU502589 carcinoma, cell line, Prostate .a 14 to 582 78 to 651       574/1344
(42 %)
27 diff
(98.0 %id)
BP330847 rectum .a 14 to 590 1 to 582       580/582
(99 %)
7 diff
(98.8 %id)
BI517594 pooled colon, kidney, stomach .a 15 to 792 1 to 778   fully sequenced,   778/778
(100 %)
1 diff
(99.9 %id)
BI818642 pooled brain, lung, testis .a 15 to 871 1 to 862       862/863
(99 %)
17 diff
(98.1 %id)
BM564207 brain, medulla .a 15 to 926 1 to 916       916/1076
(85 %)
9 diff
(99.2 %id)
BQ887136 carcinoma, cell line, Prostate .a 15 to 899 1 to 892       892/899
(99 %)
15 diff
(98.4 %id)
TI_57196547   .a 15 to 871 29 to 890       862/891
(96 %)
22 diff
(97.6 %id)
TI_45236003   .a 15 to 792 71 to 848   fully sequenced,   778/848
(91 %)
7 diff
(99.2 %id)
CR990503 T-Lymphocytes .a 15 to 758 1 to 748       746/758
(98 %)
7 diff
(99.1 %id)
BG338518 leiomyosarcoma cell line, uterus .a 16 to 761 1 to 751       751/1087
(69 %)
21 diff
(98.1 %id)
BQ425917 melanotic melanoma, skin .a 16 to 864 1 to 857       857/870
(98 %)
10 diff
(98.9 %id)
BQ434697 melanotic melanoma, skin .a 16 to 808 1 to 796       795/890
(89 %)
9 diff
(99.0 %id)
BU557305 ovary, teratocarcinoma, cell line .a 16 to 860 28 to 880       853/924
(92 %)
21 diff
(97.8 %id)
BM916239 amelanotic melanoma, cell line, skin .a 17 to 424 1 to 409       409/1313
(31 %)
7 diff
(99.5 %id)
BQ057268 lymph, lymphoma, cell line .a 17 to 476 1 to 462       462/1169
(39 %)
10 diff
(99.2 %id)
BQ059629 lymph, lymphoma, cell line .a 17 to 796 1 to 780       780/1039
(75 %)
2 diff
(99.9 %id)
BU855366 ovary, teratocarcinoma, cell line .a 17 to 573 1 to 559       559/873
(64 %)
9 diff
(99.0 %id)
BU855500 ovary, teratocarcinoma, cell line .a 17 to 844 1 to 838       838/838
(100 %)
19 diff
(97.8 %id)
BF183906 bone marrow, from chronic myelogenous leukemia .a 18 to 647 1 to 628       628/882
(71 %)
11 diff
(98.8 %id)
BU855200 ovary, teratocarcinoma, cell line .a 18 to 796 1 to 782       782/855
(91 %)
7 diff
(99.2 %id)
BI193049 epithelioid carcinoma cell line, Pancreas .a 19 to 761 1 to 742       742/761
(97 %)
5 diff
(99.4 %id)
BU844599 ovary, teratocarcinoma, cell line .a 19 to 926 1 to 918       918/921
(99 %)
19 diff
(98.0 %id)
TI_43961695   .a 19 to 676 62 to 728       665/728
(91 %)
27 diff
(96.3 %id)
TI_57183953   .a 19 to 808 35 to 827       793/892
(88 %)
15 diff
(98.4 %id)
TI_57172874   .a 19 to 760 32 to 791       733/860
(85 %)
48 diff
(94.5 %id)
BX371134 Placenta Cot 25-normalized .a 20 to 924 1 to 897       897/897
(100 %)
18 diff
(98.0 %id)
CX785226 human embryonic stem cells .a 21 to 675 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
DR157154 human embryonic stem cells differentiated toan early endodermal cell type .a 21 to 752 1 to 732       732/732
(100 %)
0 diff
(100 %id)
AA355848   .a 22 to 265 1 to 246       244/246
(99 %)
4 diff
(98.4 %id)
CD607769   .a 22 to 761 1 to 745       741/752
(98 %)
18 diff
(97.7 %id)
BF316377 brain, neuroblastoma .a 22 to 746 1 to 719       721/766
(94 %)
30 diff
(96.1 %id)
BI335003 cervical carcinoma cell line, cervix .a 22 to 908 1 to 894       867/903
(96 %)
18 diff
(98.1 %id)
BI830700 brain, medulla .a 22 to 760 1 to 757       730/826
(88 %)
44 diff
(94.7 %id)
BI489774 pooled brain, lung, testis .a 22 to 676 1 to 664       662/664
(99 %)
32 diff
(95.2 %id)
BI757846 brain .a 22 to 415 1 to 401       401/1077
(37 %)
10 diff
(99.1 %id)
BI767863 pooled lung and spleen .a 22 to 808 1 to 790       790/855
(92 %)
10 diff
(98.9 %id)
CD247017 embryonic stem cells, WA01, passage 38 .a 23 to 758 15 to 754       740/833
(88 %)
13 diff
(98.5 %id)
CR614466 fetal liver .a 23 to 1472 1 to 1450 exact     1450/1450
(100 %)
0 diff
(100 %id)
BX427312 fetal liver, Liver .a 23 to 792 1 to 770   fully sequenced,   770/770
(100 %)
2 diff
(99.8 %id)
BQ952074 epidermoid carcinoma, cell line, lung .a 23 to 809 1 to 792       790/833
(94 %)
14 diff
(98.4 %id)
BQ054636 lymph, lymphoma, cell line .a 24 to 758 1 to 737       737/1012
(72 %)
16 diff
(98.5 %id)
BQ063409 lymph, lymphoma, cell line .a 24 to 928 1 to 918       916/1039
(88 %)
21 diff
(98.0 %id)
BQ064862 lymph, lymphoma, cell line .a 24 to 926 1 to 914       912/1040
(87 %)
23 diff
(97.8 %id)
BQ276390 carcinoma, cell line, Prostate .a 24 to 801 1 to 778       778/1061
(73 %)
6 diff
(99.5 %id)
BQ642203 lymph, lymphoma, cell line .a 24 to 711 1 to 693       691/828
(83 %)
8 diff
(99.1 %id)
TI_57238133   .a 24 to 917 22 to 914       893/915
(97 %)
23 diff
(97.5 %id)
BF977673 melanotic melanoma, high MDR, skin .a 26 to 744 1 to 725       717/835
(85 %)
46 diff
(94.5 %id)
CN343426 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 27 to 540 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
CN343428 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 27 to 494 1 to 468       468/473
(98 %)
1 diff
(99.8 %id)
CN343429 embryonic stem cells, DMSO-treated H9 cellline .a 27 to 183 1 to 157       157/157
(100 %)
1 diff
(99.4 %id)
BF242828 bone marrow, from acute myelogenous leukemia .a 27 to 710 1 to 683       681/822
(82 %)
40 diff
(95.2 %id)
BI912864 brain .a 29 to 917 1 to 888       888/889
(99 %)
18 diff
(98.0 %id)
BQ057860 lymph, lymphoma, cell line .a 30 to 918 21 to 922       902/1048
(86 %)
20 diff
(98.1 %id)
BM738224 Ascites, stomach .a 30 to 356 1 to 324       322/324
(99 %)
11 diff
(96.7 %id)
AA325010 brain, cerebellum .a 31 to 341 1 to 312       312/312
(100 %)
2 diff
(99.4 %id)
BE870227 adenocarcinoma, colon .a 31 to 654 1 to 622       622/622
(100 %)
4 diff
(99.4 %id)
BU187557 eye, retinoblastoma .a 31 to 809 12 to 793       782/897
(87 %)
14 diff
(98.5 %id)
AU127947   .a 31 to 568 2 to 538   capped   537/567
(94 %)
4 diff
(99.3 %id)
BE253648 eye, retinoblastoma .a 34 to 759 1 to 727       727/805
(90 %)
17 diff
(97.9 %id)
BQ065626 lymph, lymphoma, cell line .a 35 to 933 1 to 904       904/1001
(90 %)
17 diff
(98.4 %id)
BC008149 Brain, anaplastic oligodendroglioma with1p/19q loss .a 38 to 1499 1 to 1462 exact available from MGC, AAA   1462/1462
(100 %)
1 diff
(100.0 %id)
BE255824 eye, retinoblastoma .a 38 to 636 1 to 596       596/596
(100 %)
3 diff
(99.5 %id)
BG469642 adenocarcinoma cell line, colon .a 38 to 871 1 to 833       833/835
(99 %)
7 diff
(99.2 %id)
BU194894 melanotic melanoma, skin .a 38 to 798 12 to 772       761/826
(92 %)
10 diff
(98.8 %id)
DR005294 Prostate .a 38 to 551 1 to 513       513/513
(100 %)
3 diff
(99.5 %id)
DA018031 adrenal gland .a 39 to 603 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CR595054 HeLa cells Cot 25-normalized .a 39 to 1467 1 to 1429 exact     1429/1429
(100 %)
0 diff
(100 %id)
BX355547 Placenta Cot 25-normalized .a 39 to 974 31 to 989       801/989
(80 %)
26 diff
(97.4 %id)
BX341696   .a 39 to 792 1 to 753   fully sequenced,   753/753
(100 %)
2 diff
(99.8 %id)
BE785743 large cell carcinoma, lung .a 39 to 756 1 to 711       713/891
(80 %)
29 diff
(96.8 %id)
BE790191 large cell carcinoma, lung .a 39 to 710 1 to 669       669/784
(85 %)
11 diff
(98.6 %id)
BG913775 anaplastic oligodendroglioma with 1p/19qloss, brain .a 39 to 790 1 to 750       750/750
(100 %)
10 diff
(98.7 %id)
CN343424 embryonic stem cells, cell lines H1, H7, andH9 .a 41 to 792 10 to 763       754/763
(98 %)
9 diff
(98.9 %id)
R87858 brain .a 41 to 415 14 to 389       378/394
(95 %)
16 diff
(96.0 %id)
BE561038 Burkitt lymphoma, lymph .a 41 to 809 1 to 770       770/1087
(70 %)
16 diff
(98.6 %id)
BQ717056 sympathetic trunk .a 41 to 758 1 to 721       721/873
(82 %)
7 diff
(99.2 %id)
BE396412 Burkitt lymphoma, lymph .a 42 to 707 1 to 666       666/666
(100 %)
1 diff
(99.9 %id)
H16288 whole brain .a 43 to 485 8 to 464       457/464
(98 %)
13 diff
(97.2 %id)
BE561477 Burkitt lymphoma, lymph .a 43 to 762 1 to 714       714/893
(79 %)
16 diff
(98.3 %id)
BI819240 pooled brain, lung, testis .a 44 to 795 1 to 752       752/752
(100 %)
2 diff
(99.8 %id)
TI_57197686   .a 44 to 795 69 to 820       752/820
(91 %)
7 diff
(99.2 %id)
BG257063 embryonal carcinoma, cell line, testis .a 45 to 758 1 to 722       720/1090
(66 %)
12 diff
(98.9 %id)
BX447624 B cells (Ramos cell line) .a 46 to 792 1 to 746   fully sequenced,   746/746
(100 %)
5 diff
(99.4 %id)
CR596302 B cells (Ramos cell line) .a 47 to 1460 1 to 1414 exact     1414/1414
(100 %)
0 diff
(100 %id)
BE889503 leiomyosarcoma, uterus .a 47 to 758 1 to 720       718/968
(74 %)
43 diff
(95.6 %id)
BE891162 melanotic melanoma, skin .a 47 to 633 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
TI_154194342   .a 48 to 917 46 to 911       866/1041
(83 %)
28 diff
(97.4 %id)
CD607770   .a 49 to 836 796 to 5       792/797
(99 %)
26 diff
(96.8 %id)
BI457758 brain, hypothalamus .a 50 to 771 1 to 722       722/725
(99 %)
14 diff
(98.1 %id)
BE870723 adenocarcinoma, colon .a 51 to 801 1 to 753       751/869
(86 %)
19 diff
(97.9 %id)
BG778996 adenocarcinoma, Prostate .a 51 to 663 1 to 613       613/616
(99 %)
11 diff
(98.3 %id)
CA489470   .a 51 to 647 1 to 598       596/840
(70 %)
7 diff
(99.2 %id)
BG385710 adenocarcinoma cell line, colon .a 52 to 645 1 to 593       593/593
(100 %)
3 diff
(99.5 %id)
AU099368   .a 55 to 354 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
AU105501   .a 55 to 104 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
BP256868 Kidney .a 55 to 635 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP195883 brain .a 57 to 638 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BE795040 lung, small cell carcinoma .a 59 to 751 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
BE870478 adenocarcinoma, colon .a 61 to 558 1 to 504       504/755
(66 %)
12 diff
(98.5 %id)
AA315769 colon .a 119 to 559 1 to 440       440/440
(100 %)
1 diff
(99.8 %id)
X04808   .a 123 to 1499 1 to 1377 E210K     1377/1377
(100 %)
2 diff
(99.9 %id)
TI_1948076417   .a 140 to 1255 128 to 1240 E258X G259R T294N Q296A A297G ... fully sequenced,   1113/1240
(89 %)
44 diff
(96.5 %id)
TI_1948076598   .a 140 to 678 128 to 666   fully sequenced,   539/666
(80 %)
5 diff
(99.3 %id)
TI_1948076777   .a 140 to 678 129 to 667   fully sequenced,   539/667
(80 %)
5 diff
(99.3 %id)
TI_1948076238   .a 149 to 678 140 to 669   fully sequenced,   530/669
(79 %)
6 diff
(99.2 %id)
CV025186 mixed .a 150 to 787 1 to 638       638/638
(100 %)
0 diff
(100 %id)
BM016499 breast, mammary adenocarcinoma, cell line .a 161 to 873 1 to 713       713/713
(100 %)
0 diff
(100 %id)
TI_59394117   .a 161 to 873 82 to 794       713/713
(100 %)
0 diff
(100 %id)
TI_154189363   .a 168 to 1061 50 to 942       895/1067
(83 %)
14 diff
(98.7 %id)
CF126383 Chondrosarcoma Lung Metastasis cell lines, lung .a 169 to 1003 1 to 834       836/834
(100 %)
6 diff
(99.3 %id)
H38510 brain .a 187 to 354 1 to 168       168/168
(100 %)
7 diff
(95.9 %id)
BE547860 cervical carcinoma cell line, cervix .a 208 to 921 1 to 718       718/804
(89 %)
12 diff
(98.6 %id)
AA324545 brain, cerebellum .a 219 to 518 1 to 300       300/300
(100 %)
0 diff
(100 %id)
BI767927 pooled lung and spleen .a 220 to 1129 1 to 919       917/920
(99 %)
16 diff
(98.3 %id)
TI_57184018   .a 220 to 1129 58 to 976       917/977
(93 %)
22 diff
(97.8 %id)
BQ323620 colon_ins .a 234 to 497 27 to 291       265/297
(89 %)
9 diff
(97.0 %id)
BQ304534 breast .a 249 to 497 256 to 8       252/269
(93 %)
0 diff
(100 %id)
CN343425 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 260 to 940 1 to 682       682/682
(100 %)
5 diff
(99.3 %id)
BM770736 Ascites, stomach .a 265 to 752 1 to 488       488/488
(100 %)
0 diff
(100 %id)
CF128434 Chondrosarcoma Lung Metastasis cell lines, lung .a 281 to 1035 1 to 755       755/755
(100 %)
0 diff
(100 %id)
TI_154194309   .a 281 to 1213 48 to 967       920/1008
(91 %)
17 diff
(98.4 %id)
BG025746 lymph, lymphoma, cell line .a 292 to 815 15 to 538       524/538
(97 %)
6 diff
(98.9 %id)
BM747492 Ascites, stomach .a 294 to 711 1 to 420       420/420
(100 %)
2 diff
(99.6 %id)
BF213889 bone marrow, from acute myelogenous leukemia .a 324 to 955 1 to 635       635/826
(76 %)
30 diff
(96.4 %id)
AA461388   .a 327 to 796 1 to 471       469/476
(98 %)
7 diff
(98.6 %id)
BI194976 brain, neuroblastoma .a 351 to 999 1 to 650       650/650
(100 %)
8 diff
(98.8 %id)
BI197960 brain, neuroblastoma .a 352 to 1302 1 to 960       960/961
(99 %)
35 diff
(96.4 %id)
BG337601 leiomyosarcoma cell line, uterus .a 354 to 1160 1 to 799       799/904
(88 %)
21 diff
(97.7 %id)
BE514746 adenocarcinoma cell line, ovary .a 376 to 1058 1 to 685       641/695
(92 %)
16 diff
(97.7 %id)
BF035760 adenocarcinoma, ovary .a 380 to 1058 1 to 678       676/801
(84 %)
6 diff
(99.3 %id)
TI_57228551   .a 425 to 1234 46 to 853       808/812
(99 %)
10 diff
(98.8 %id)
BI869503 adenocarcinoma, cell line, Liver .a 426 to 1234 1 to 807       807/811
(99 %)
10 diff
(98.8 %id)
BX375361 Neuroblastoma Cot 25-normalized .a 430 to 1472 1043 to 12       1032/1057
(97 %)
21 diff
(98.1 %id)
T80125 liver and spleen .a 475 to 645 171 to 1       171/171
(100 %)
4 diff
(97.7 %id)
AW407294 lymph .a 484 to 803 17 to 335       319/340
(93 %)
10 diff
(97.1 %id)
TI_57176090   .a 490 to 1200 26 to 734       709/735
(96 %)
8 diff
(99.0 %id)
CD607767   .a 496 to 747 257 to 5       253/263
(96 %)
0 diff
(100 %id)
CD607768   .a 496 to 747 8 to 260       253/265
(95 %)
13 diff
(95.1 %id)
BI829351 brain, medulla .a 497 to 1200 1 to 702       702/703
(99 %)
3 diff
(99.6 %id)
BQ688434 ductal carcinoma, cell line, Pancreas .a 501 to 1153 1 to 660       658/973
(67 %)
21 diff
(97.9 %id)
R99229 liver and spleen .a 504 to 926 1 to 431       431/439
(98 %)
18 diff
(95.9 %id)
BP271609   .a 510 to 1136 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
BI857976 breast, mammary adenocarcinoma, cell line .a 564 to 1303 1 to 741       741/741
(100 %)
2 diff
(99.8 %id)
TI_57191169   .a 564 to 1303 57 to 797       741/741
(100 %)
2 diff
(99.8 %id)
CD607771   .a 573 to 842 1 to 269       269/270
(99 %)
5 diff
(98.2 %id)
CD607772   .a 579 to 840 262 to 1       262/268
(97 %)
0 diff
(100 %id)
BQ945035 epidermoid carcinoma, cell line, lung .a 592 to 1453 1 to 874       874/937
(93 %)
20 diff
(97.9 %id)
AL520284 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 617 to 1486 866 to 1   fully sequenced,   866/866
(100 %)
6 diff
(99.4 %id)
AL579416 T cells (Jurkat cell line), T cells from T cell leukemia .a 617 to 1457 842 to 1   fully sequenced,   842/842
(100 %)
26 diff
(97.0 %id)
BX358896 Placenta Cot 25-normalized .a 617 to 1467 848 to 1   fully sequenced,   848/848
(100 %)
4 diff
(99.6 %id)
TI_1948076239   .a 617 to 1233 742 to 120   fully sequenced,   629/748
(84 %)
8 diff
(99.0 %id)
TI_1948076599   .a 617 to 1233 740 to 115   fully sequenced,   635/749
(84 %)
56 diff
(92.6 %id)
TI_1948076778   .a 617 to 1233 739 to 114   fully sequenced,   635/748
(84 %)
56 diff
(92.6 %id)
BG421936 Kidney, renal cell adenocarcinoma .a 648 to 1451 1 to 799   AAA   799/833
(95 %)
30 diff
(96.4 %id)
BM808229 amelanotic melanoma, cell line, skin .a 648 to 1499 875 to 22   AAA Submitted on the opposite strand 854/975
(87 %)
5 diff
(99.5 %id)
M60888   .a 648 to 761 1 to 114       114/114
(100 %)
1 diff
(99.2 %id)
TI_227713638   .a 648 to 1494 912 to 66   AAA   847/1012
(83 %)
9 diff
(99.2 %id)
H38188 liver and spleen .a 650 to 739 1 to 90       90/90
(100 %)
0 diff
(100 %id)
TI_149311703   .a 651 to 1500 926 to 88   AAA   839/926
(90 %)
15 diff
(98.4 %id)
BE739550 hypernephroma, Kidney .a 671 to 1432 777 to 25       753/1044
(72 %)
14 diff
(98.7 %id)
TI_1948076418   .a 725 to 1233 635 to 118   fully sequenced,   527/644
(81 %)
56 diff
(91.4 %id)
BX447623 B cells (Ramos cell line) .a 731 to 1460 729 to 1   fully sequenced,   729/729
(100 %)
13 diff
(98.3 %id)
BX341695   .a 731 to 1444 738 to 26   fully sequenced,   713/738
(96 %)
1 diff
(99.9 %id)
BX427311 fetal liver, Liver .a 731 to 1466 740 to 6   fully sequenced,   735/740
(99 %)
2 diff
(99.8 %id)
BI518130 pooled colon, kidney, stomach .a 731 to 1454 741 to 1   fully sequenced,   741/741
(100 %)
21 diff
(97.2 %id)
TI_45236004   .a 731 to 1454 741 to 1   fully sequenced,   741/741
(100 %)
21 diff
(97.2 %id)
TI_149293977   .a 768 to 1500 813 to 84   AAA   730/930
(78 %)
4 diff
(99.6 %id)
CD742653 Alveolar Macrophage, lung .a 774 to 1494 740 to 19   AAA   722/722
(100 %)
1 diff
(99.9 %id)
TI_149284301   .a 801 to 1500 793 to 98   AAA   696/776
(89 %)
6 diff
(99.3 %id)
BU682895 lung .a 809 to 1500 710 to 19   AAA   692/692
(100 %)
2 diff
(99.8 %id)
BM977484 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 809 to 1500 709 to 19   AAA   691/691
(100 %)
1 diff
(99.9 %id)
BM975748 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 810 to 1500 710 to 19   AAA   692/692
(100 %)
1 diff
(99.9 %id)
BF219922 lung, small cell carcinoma .a 813 to 1448 640 to 1       640/640
(100 %)
7 diff
(99.0 %id)
TI_154033124   .a 821 to 1498 747 to 70   AAA   678/955
(70 %)
7 diff
(99.3 %id)
BQ772512 Chondrosarcoma Cell line .a 822 to 1500 698 to 19   AAA   680/680
(100 %)
1 diff
(99.9 %id)
BU632490 cell lines, Chondrosarcoma .a 827 to 1500 692 to 19   AAA   674/674
(100 %)
0 diff
(100 %id)
BQ020524 Fibrosarcoma .a 853 to 1501 667 to 19   AAA   649/649
(100 %)
0 diff
(100 %id)
BM991212 lung, Lung Focal Fibrosis .a 858 to 1494 656 to 19   AAA   638/653
(97 %)
1 diff
(99.9 %id)
BU624067 cell lines, Enchondroma .a 861 to 1498 654 to 19   AAA   636/636
(100 %)
1 diff
(99.9 %id)
CD369303 Alveolar Macrophage, lung .a 861 to 1499 656 to 19   AAA   638/638
(100 %)
4 diff
(99.4 %id)
CA443354 lung, Metastatic Chondrosarcoma .a 862 to 1498 655 to 19   AAA   637/637
(100 %)
2 diff
(99.7 %id)
CA425090 cell lines, Chondrosarcoma .a 862 to 1500 658 to 19   AAA   640/640
(100 %)
1 diff
(99.9 %id)
AW269857 lung, two pooled squamous cell carcinomas .a 866 to 1501 640 to 4       637/640
(99 %)
5 diff
(99.3 %id)
BU680464 lung .a 899 to 1500 620 to 19   AAA   602/603
(99 %)
1 diff
(99.9 %id)
BQ773507 Chondrosarcoma Cell line .a 908 to 1498 610 to 19   AAA   592/594
(99 %)
1 diff
(99.9 %id)
BF196496 Kidney .a 912 to 1499 588 to 1       588/588
(100 %)
2 diff
(99.7 %id)
AW151030 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 917 to 1501 604 to 18   AAA   587/615
(95 %)
22 diff
(96.5 %id)
BM047404 carcinoma, cell line, Prostate .a 919 to 1498 1 to 580       580/1000
(58 %)
2 diff
(99.8 %id)
CA424363 cell lines, Chondrosarcoma .a 921 to 1499 599 to 19   AAA   581/581
(100 %)
2 diff
(99.7 %id)
AI114715 Liver .a 925 to 1499 1 to 574       574/575
(99 %)
3 diff
(99.5 %id)
AW516858 cervix, tumor .a 931 to 1498 570 to 3       568/570
(99 %)
3 diff
(99.5 %id)
AA584045 larynx .a 937 to 1500 564 to 3       562/564
(99 %)
2 diff
(99.7 %id)
AW245473 lung, small cell carcinoma .a 943 to 1499 567 to 11   AAA   557/557
(100 %)
0 diff
(100 %id)
AU160591   .a 950 to 1499 548 to 1       548/550
(99 %)
9 diff
(98.4 %id)
AA495858.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 970 to 1495 1 to 522     also hits gene ADNP 522/522
(100 %)
6 diff
(98.9 %id)
DB365037   .a 976 to 1501 526 to 1       526/585
(89 %)
9 diff
(98.5 %id)
R99230 liver and spleen .a 1045 to 1499 472 to 7       466/479
(97 %)
0 diff
(100 %id)
AA099316 colon, tumor .a 1134 to 1497 367 to 1       367/375
(97 %)
5 diff
(98.7 %id)
R87775 brain .a 1160 to 1484 330 to 6       325/330
(98 %)
0 diff
(100 %id)
H38511 brain .a 1199 to 1485 287 to 1       287/287
(100 %)
0 diff
(100 %id)
H16469 whole brain .a 1405 to 1495 91 to 1       91/91
(100 %)
0 diff
(100 %id)
AU120403 whole embryo, mainly body .b 1 to 809 2 to 807   tiling clone, capped   806/806
(100 %)
5 diff
(99.4 %id)
AL531360 brain, fetal liver, Liver, neuroblastoma cells .b 21 to 763 1 to 744   tiling clone, fully sequenced,   744/744
(100 %)
2 diff
(99.8 %id)
T57423 fetal spleen, Spleen .b 30 to 321 1 to 292       292/418
(69 %)
3 diff
(99.3 %id)
AL564037 brain, fetal liver, Liver, neuroblastoma cells .b 702 to 1528 827 to 1   tiling clone, fully sequenced,   827/827
(100 %)
20 diff
(97.6 %id)
AU146475 whole embryo, mainly body .b 1057 to 1585 528 to 1   tiling clone,   528/548
(96 %)
11 diff
(98.0 %id)
T57343 fetal spleen, Spleen .b 1231 to 1404 177 to 1       177/210
(84 %)
3 diff
(98.6 %id)
AL520223 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1 to 742 1 to 739   fully sequenced,   739/739
(100 %)
9 diff
(98.8 %id)
CR611708 Neuroblastoma Cot 10-normalized .c 2 to 1549 1 to 1548 exact tiling clone,   1548/1548
(100 %)
0 diff
(100 %id)
AL561865 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 681 to 1549 869 to 1   fully sequenced,   869/869
(100 %)
6 diff
(99.4 %id)
BI012059 lung_normal .d 1 to 409 407 to 1   tiling clone,   407/414
(98 %)
8 diff
(98.1 %id)
BI012141 lung_normal .d 11 to 409 398 to 1   tiling clone,   398/398
(100 %)
5 diff
(98.8 %id)
BI012148 lung_normal .d 11 to 291 285 to 8       278/285
(97 %)
0 diff
(100 %id)
BI011976 lung_normal .d 12 to 409 9 to 419   tiling clone,   411/419
(98 %)
6 diff
(98.6 %id)
DA125089 cerebellum .d 325 to 842 2 to 517   tiling clone, capped   516/516
(100 %)
4 diff
(99.3 %id)
BU662080 blood .d 791 to 1355 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BU661733 blood .d 808 to 1259 24 to 475       452/475
(95 %)
6 diff
(98.8 %id)
BU665028 blood .d 808 to 1491 12 to 695   tiling clone,   684/695
(98 %)
7 diff
(99.0 %id)
NM_001024382.1   .d 808 to 2218 1 to 1411 exact RefSeq, AAA   1411/1411
(100 %)
0 diff
(100 %id)
BI771840 pooled lung and spleen .d 826 to 1380 1 to 555   tiling clone,   555/557
(99 %)
1 diff
(99.9 %id)
TI_57179576   .d 826 to 1380 36 to 590       555/592
(93 %)
7 diff
(98.9 %id)
X04217   .d 837 to 2216 1 to 1380 N332T tiling clone,   1380/1380
(100 %)
4 diff
(99.8 %id)
CR620096 Neuroblastoma Cot 25-normalized .e 1 to 1537 1 to 1537 exact tiling clone,   1537/1537
(100 %)
0 diff
(100 %id)
BX376278 Neuroblastoma Cot 25-normalized .e 1 to 747 1 to 746   fully sequenced,   746/746
(100 %)
6 diff
(99.2 %id)
AW250727 lung, small cell carcinoma .e 12 to 587 1 to 576       576/576
(100 %)
4 diff
(99.4 %id)
CR611265 Neuroblastoma Cot 25-normalized .e 32 to 1552 1 to 1521 exact     1521/1521
(100 %)
0 diff
(100 %id)
BX343411 Neuroblastoma Cot 25-normalized .e 32 to 999 1 to 962       962/997
(96 %)
13 diff
(98.7 %id)
BX375362 Neuroblastoma Cot 25-normalized .e 32 to 1002 1 to 967       967/1008
(95 %)
14 diff
(98.7 %id)
BX376277 Neuroblastoma Cot 25-normalized .e 686 to 1537 853 to 1   fully sequenced,   853/853
(100 %)
8 diff
(99.1 %id)
R55458 breast .e 1118 to 1469 19 to 375   fully sequenced,   357/375
(95 %)
13 diff
(96.6 %id)
DB520870 testis .e 1124 to 1567 1 to 444     Submitted on the opposite strand 444/446
(99 %)
4 diff
(99.2 %id)
AI760311 pooled .e 1128 to 1568 445 to 7       439/448
(97 %)
0 diff
(100 %id)
AI004710   .e 1129 to 1568 447 to 10       438/492
(89 %)
0 diff
(100 %id)
AW139390   .e 1133 to 1570 455 to 18   AAA   438/438
(100 %)
1 diff
(99.8 %id)
AA812418 epithelium (cell line), Prostate .e 1142 to 1566 427 to 1       427/427
(100 %)
25 diff
(94.2 %id)
BF528298 anaplastic oligodendroglioma with 1p/19qloss, brain .e 1144 to 1570 1 to 427   AAA   427/427
(100 %)
0 diff
(100 %id)
BM760947 Ascites, stomach .e 1147 to 1569 1 to 422   AAA   422/422
(100 %)
1 diff
(99.8 %id)
BM759426 Ascites, stomach .e 1148 to 1503 1 to 355       355/355
(100 %)
1 diff
(99.8 %id)
TI_149313096   .e 1151 to 1570 503 to 85   AAA   419/953
(43 %)
7 diff
(99.3 %id)
AI565317 Kidney .e 1156 to 1568 429 to 11   AAA   419/419
(100 %)
19 diff
(95.5 %id)
BM739254 Ascites, stomach .e 1157 to 1569 1 to 412   AAA   412/412
(100 %)
1 diff
(99.8 %id)
BG528956 adenocarcinoma, Prostate .e 1169 to 1568 1 to 399   AAA   399/399
(100 %)
1 diff
(99.8 %id)
AI989750 colon, colonic mucosa from 3 patients with Crohn'sdisease .e 1182 to 1568 398 to 12   AAA   387/387
(100 %)
0 diff
(100 %id)
AA916630 adenocarcinoma, colon .e 1186 to 1569 390 to 1       390/390
(100 %)
28 diff
(92.9 %id)
AA732393 germinal center B cell .e 1231 to 1569 350 to 12   AAA   339/459
(73 %)
3 diff
(99.4 %id)
AI205607 lung .e 1237 to 1567 327 to 1       327/342
(95 %)
16 diff
(95.4 %id)
AW134720   .e 1246 to 1569 341 to 18   AAA   324/324
(100 %)
0 diff
(100 %id)
BE711240 head_neck .e 1248 to 1516 269 to 1       269/270
(99 %)
0 diff
(100 %id)
CF541150 lung .e 1249 to 1570 341 to 19   AAA   323/323
(100 %)
1 diff
(99.7 %id)
AA724756 pooled .e 1258 to 1570 324 to 5       320/329
(97 %)
0 diff
(100 %id)
BF592935 pooled germ cell tumors .e 1270 to 1568 299 to 1       299/299
(100 %)
1 diff
(99.7 %id)
AW263902 carcinoma in situ from retromolar trigone .e 1279 to 1568 322 to 33   AAA   290/296
(97 %)
3 diff
(99.0 %id)
AW246873 lung, small cell carcinoma .e 1342 to 1569 266 to 39   AAA   228/228
(100 %)
6 diff
(97.4 %id)
AI417932 Prostate .e 1347 to 1568 222 to 1       222/222
(100 %)
0 diff
(100 %id)
AI969808 Prostate .e 1349 to 1568 228 to 9       220/228
(96 %)
0 diff
(100 %id)
AA658178   .e 1383 to 1568 1 to 186       186/186
(100 %)
0 diff
(100 %id)
CA420848 Bone, Enchondroma cell line .e 1397 to 1569 191 to 19   AAA   173/173
(100 %)
1 diff
(99.5 %id)
EC535625 Prostate .e 1410 to 1515 1 to 104       104/104
(100 %)
6 diff
(94.3 %id)
EC505377 Prostate .e 1412 to 1515 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
R54734 breast .e 1439 to 1568 139 to 1   fully sequenced,   139/139
(100 %)
0 diff
(100 %id)
EC572371 Prostate .e 1468 to 1568 102 to 3       100/105
(95 %)
0 diff
(100 %id)
CA308016 Alveolar Macrophage, lung .e 1468 to 1568 119 to 19   AAA   101/101
(100 %)
1 diff
(99.1 %id)
AA236740 germinal center B cell .e 1533 to 1779 1 to 247   tiling clone,   247/247
(100 %)
1 diff
(99.6 %id)
BG399920 Kidney .f 1 to 702 2 to 703   tiling clone,   703/888
(79 %)
20 diff
(97.8 %id)
BG774935 carcinoma, cell line, Prostate .f 26 to 738 1 to 713   fully sequenced,   713/713
(100 %)
1 diff
(99.9 %id)
CN419878 embryonic stem cells, cell lines H1, H7, andH9 .f 40 to 494 1 to 455       455/455
(100 %)
2 diff
(99.6 %id)
CX785831 human embryonic stem cells .f 40 to 842 1 to 803   tiling clone,   803/803
(100 %)
0 diff
(100 %id)
BG775394 carcinoma, cell line, Prostate .f 677 to 1395 727 to 7   tiling clone, fully sequenced,   721/727
(99 %)
1 diff
(99.9 %id)
CR603362 neuroblastoma .g 1 to 1347 1 to 1347 exact tiling clone,   1347/1347
(100 %)
0 diff
(100 %id)
AL516000 brain, neuroblastoma, neuroblastoma cells .g 1 to 643 1 to 642   fully sequenced,   642/642
(100 %)
3 diff
(99.6 %id)
AL515999 brain, neuroblastoma, neuroblastoma cells .g 613 to 1162 735 to 186   fully sequenced,   550/735
(74 %)
9 diff
(98.8 %id)
AU128671   .h 1 to 639 2 to 640   tiling clone, capped   639/639
(100 %)
7 diff
(99.0 %id)
AK131072 Spleen .h 30 to 1380 1 to 1351 exact tiling clone, available from FLJ,   1351/1351
(100 %)
0 diff
(100 %id)
AU150925   .h 857 to 1379 522 to 1       520/567
(91 %)
15 diff
(97.4 %id)
BQ073284 epidermoid carcinoma, cell line, lung .i 1 to 794 1 to 796   tiling clone,   796/1014
(78 %)
6 diff
(99.5 %id)
CR606553 Neuroblastoma Cot 10-normalized .i 6 to 1549 1 to 1544 exact tiling clone,   1544/1544
(100 %)
0 diff
(100 %id)
AL519384 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .i 6 to 884 1 to 933       894/985
(90 %)
25 diff
(97.5 %id)
AL561775 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .i 871 to 1549 676 to 1       676/813
(83 %)
3 diff
(99.7 %id)
AK000628   .j 1 to 1469 1 to 1469 exact tiling clone, available from FLJ, AAA   1469/1469
(100 %)
1 diff
(100.0 %id)
BP272461   .j 1 to 597 1 to 598       598/598
(100 %)
8 diff
(98.7 %id)
DB038608 testis .j 7 to 494 2 to 490   capped   489/489
(100 %)
4 diff
(99.2 %id)
CN419879 embryonic stem cells, cell lines H1, H7, andH9 .j 14 to 700 12 to 701       690/701
(98 %)
6 diff
(99.2 %id)
BG034526 breast, mammary adenocarcinoma, cell line .j 15 to 645 1 to 626   tiling clone,   626/926
(67 %)
4 diff
(99.6 %id)
BP273689   .j 29 to 583 1 to 553       553/580
(95 %)
18 diff
(96.9 %id)
BM763283 myeloma .j 30 to 641 1 to 611       613/611
(100 %)
12 diff
(98.1 %id)
BM763135 myeloma .j 30 to 625 1 to 594       596/594
(100 %)
7 diff
(98.9 %id)
BM785257 myeloma .j 30 to 627 1 to 596       598/596
(100 %)
13 diff
(97.9 %id)
BG180160 adenocarcinoma, cell line, Prostate .j 360 to 1123 1 to 751       751/963
(77 %)
23 diff
(97.7 %id)
BQ213349 melanotic melanoma, skin .j 461 to 1040 1 to 581       581/1044
(55 %)
10 diff
(99.1 %id)
AU118927 whole embryo, mainly head .k 1 to 859 2 to 873   tiling clone, capped   868/882
(98 %)
20 diff
(97.8 %id)
W87695 liver and spleen .k 994 to 1414 2 to 423   tiling clone,   422/423
(99 %)
6 diff
(98.6 %id)
AA424818 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k 1321 to 1848 533 to 7       527/536
(98 %)
1 diff
(99.9 %id)
AI040064   .k 1321 to 1849 533 to 6       528/599
(88 %)
9 diff
(98.5 %id)
AA621918 colon, colon tumor RER+ .k 1322 to 1775 458 to 1       458/478
(95 %)
16 diff
(96.7 %id)
AA918349 adenocarcinoma, colon .k 1322 to 1850 529 to 1   tiling clone,   529/529
(100 %)
6 diff
(98.9 %id)
AI417693 Prostate .k 1322 to 1841 521 to 6       516/524
(98 %)
1 diff
(99.9 %id)
BG950140 colon .k 1325 to 1700 26 to 403       378/403
(93 %)
7 diff
(98.3 %id)
AU145376 whole embryo, mainly head .k 1325 to 1850 524 to 1       524/556
(94 %)
6 diff
(99.0 %id)
AI017907 pooled .k 1325 to 1848 524 to 2       523/524
(99 %)
2 diff
(99.7 %id)
AW468417 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .k 1325 to 1844 549 to 30   AAA   520/567
(91 %)
13 diff
(97.8 %id)
AI610535 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k 1329 to 1847 519 to 1       519/575
(90 %)
27 diff
(95.4 %id)
BX343410 Neuroblastoma Cot 25-normalized .k 1334 to 1826 496 to 1       496/744
(66 %)
31 diff
(95.9 %id)
AA461207.
matches multiple genes
  .k 1341 to 1849 516 to 9     also hits gene CD151 508/516
(98 %)
0 diff
(100 %id)
AI220972 placenta .k 1344 to 1848 503 to 1       503/503
(100 %)
15 diff
(97.1 %id)
EC497228 Prostate .k 1361 to 1451 1 to 91       91/92
(98 %)
7 diff
(92.4 %id)
EC540554 Prostate .k 1364 to 1451 1 to 88       88/89
(98 %)
4 diff
(95.6 %id)
EC554196 Prostate .k 1365 to 1451 1 to 88       88/89
(98 %)
2 diff
(97.8 %id)
AA668625 bone marrow stroma .k 1365 to 1849 485 to 1       485/485
(100 %)
3 diff
(99.4 %id)
AI272085 Kidney .k 1378 to 1851 470 to 2   tiling clone,   469/470
(99 %)
5 diff
(99.0 %id)
EC508034 Prostate .k 1379 to 1462 84 to 1       84/84
(100 %)
1 diff
(98.9 %id)
AW628721 pooled .k 1382 to 1848 468 to 2       467/468
(99 %)
1 diff
(99.8 %id)
BX283668 amelanotic melanoma, cell line, skin .k 1384 to 1849 490 to 25   AAA Submitted on the opposite strand 466/466
(100 %)
0 diff
(100 %id)
AI147278 brain, glioblastoma (pooled) .k 1385 to 1851 467 to 2       466/467
(99 %)
0 diff
(100 %id)
AI192750 lung .k 1385 to 1850 471 to 6       466/471
(98 %)
0 diff
(100 %id)
BM852928 Ascites, stomach .k 1385 to 1850 1 to 466       466/475
(98 %)
1 diff
(99.8 %id)
BM794073 Ascites, stomach .k 1391 to 1837 1 to 448       448/448
(100 %)
10 diff
(97.8 %id)
BG339222 leiomyosarcoma cell line, uterus .l 1 to 792 2 to 792   tiling clone,   792/849
(93 %)
34 diff
(96.0 %id)
BE905261 epithelioid carcinoma, Pancreas .l 6 to 801 1 to 791 I187H L188P A189G T190Q A191Q ... tiling clone,   791/795
(99 %)
21 diff
(97.4 %id)
BX494644 Liver .l 728 to 1275 32 to 579   tiling clone,   548/579
(94 %)
7 diff
(98.8 %id)
N72530 liver and spleen .l 1051 to 1407 1 to 356   tiling clone,   356/356
(100 %)
15 diff
(95.8 %id)
N53571 liver and spleen .l 1798 to 2299 513 to 10   tiling clone,   504/513
(98 %)
2 diff
(99.7 %id)
BM564213 brain, medulla .m 1 to 1009 15 to 1045 V202G Q204A I205D L206P H207A ... tiling clone,   1031/1113
(92 %)
62 diff
(94.5 %id)
TI_57184149   .n 1 to 880 36 to 923 R156G L157F R158G K159S L160W ... tiling clone,   888/924
(96 %)
40 diff
(95.7 %id)
BI770785 pooled lung and spleen .n 2 to 880 1 to 887 R156G L157F R158G K159S L160W ... tiling clone,   887/888
(99 %)
34 diff
(96.2 %id)
TI_57183534   .o -9 to 864 17 to 894 K115R T116P L117* tiling clone,   878/910
(96 %)
23 diff
(97.5 %id)
BI770626 pooled lung and spleen .o 1 to 864 1 to 866 K115R T116P L117* tiling clone,   866/882
(98 %)
18 diff
(98.0 %id)
CR590157 fetal liver .p 1 to 1766 1 to 1766 exact tiling clone,   1766/1766
(100 %)
0 diff
(100 %id)
BX444065 fetal liver, Liver .p 1 to 873 1 to 874   fully sequenced,   874/874
(100 %)
2 diff
(99.8 %id)
BX444064 fetal liver, Liver .p 843 to 1737 923 to 29   fully sequenced,   895/923
(96 %)
8 diff
(99.2 %id)
TI_149299411   .p 983 to 1796 895 to 93   tiling clone, AAA   803/944
(85 %)
13 diff
(98.7 %id)
TI_159691315   .p 998 to 1792 930 to 143       788/1109
(71 %)
17 diff
(98.5 %id)
BM912584 amelanotic melanoma, cell line, skin .q 1 to 642 23 to 667   tiling clone,   645/1128
(57 %)
23 diff
(98.0 %id)
BM559781 amelanotic melanoma, cell line, skin .q 3 to 710 1 to 713 L167P Q168A R169A M170H W172A ... tiling clone,   713/1063
(67 %)
9 diff
(99.2 %id)
DA839605 placenta .r 1 to 552 2 to 554   tiling clone, capped   553/553
(100 %)
4 diff
(99.3 %id)
BQ641490 eye, normal pigmented retinal epithelium .r 3 to 821 1 to 816 H109P P110Q K111N F112L V113L ... tiling clone,   816/919
(88 %)
12 diff
(98.7 %id)
DA164225 amygdala .r 22 to 582 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
TI_151769833   .r 43 to 746 99 to 800   tiling clone,   702/1056
(66 %)
12 diff
(98.9 %id)
AK309544 lung .s 1 to 1278 5 to 1282 R120W tiling clone,   1282/1282
(100 %)
2 diff
(99.9 %id)
DA594198 lung .s 1 to 556 5 to 561   capped   560/561
(99 %)
3 diff
(99.5 %id)
DA309795 hippocampus .s 2 to 449 2 to 449   capped   448/448
(100 %)
2 diff
(99.6 %id)
BI756158 brain .s 9 to 898 1 to 892   tiling clone,   890/905
(98 %)
18 diff
(98.1 %id)
BG471676 eye, retinoblastoma .s 31 to 618 1 to 602       602/634
(94 %)
27 diff
(95.8 %id)
BE253667 eye, retinoblastoma .s 52 to 834 1 to 779       779/829
(93 %)
29 diff
(96.6 %id)
TI_57220987   .s 183 to 898 242 to 959       860/972
(88 %)
36 diff
(96.3 %id)
TI_57177860   .t 1 to 734 34 to 767   tiling clone,   734/767
(95 %)
6 diff
(99.3 %id)
BI766218 pooled lung and spleen .t 5 to 734 1 to 730       730/730
(100 %)
0 diff
(100 %id)
T84134 liver and spleen .t 10 to 336 1 to 331       331/331
(100 %)
19 diff
(94.3 %id)
R06321 liver and spleen .t 11 to 336 1 to 336       336/366
(91 %)
15 diff
(96.0 %id)
AW950326   .t 320 to 844 1 to 525   AAA   525/558
(94 %)
7 diff
(98.8 %id)
T89374 liver and spleen .t 460 to 863 416 to 1       416/455
(91 %)
17 diff
(96.3 %id)
R06263 liver and spleen .t 537 to 876 342 to 1   tiling clone,   342/342
(100 %)
4 diff
(98.9 %id)
BG394525 eye, retinoblastoma .u 1 to 716 1 to 724   tiling clone,   722/796
(90 %)
21 diff
(97.4 %id)
BG396391 eye, retinoblastoma .u 1 to 750 1 to 749   tiling clone,   749/752
(99 %)
13 diff
(98.3 %id)
BG471976 eye, retinoblastoma .u 1 to 645 1 to 652       652/653
(99 %)
28 diff
(95.8 %id)
BE256709 eye, retinoblastoma .u 20 to 757 1 to 738   tiling clone,   738/848
(87 %)
13 diff
(98.5 %id)
BE258829 eye, retinoblastoma .u 20 to 668 1 to 638       638/705
(90 %)
18 diff
(97.5 %id)
BE250920 eye, retinoblastoma .u 21 to 596 1 to 576       576/578
(99 %)
4 diff
(99.4 %id)
BE257284 eye, retinoblastoma .u 21 to 487 1 to 467       467/467
(100 %)
6 diff
(98.8 %id)
BE257178 eye, retinoblastoma .u 21 to 670 1 to 667       665/679
(97 %)
44 diff
(93.6 %id)
BE255287 eye, retinoblastoma .u 21 to 623 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BE252318 eye, retinoblastoma .u 22 to 611 1 to 593       593/672
(88 %)
13 diff
(98.1 %id)
BQ712333 Spleen .u 25 to 786 15 to 790 N114K L115P N116Q T117H R118P ... tiling clone,   774/931
(83 %)
30 diff
(96.8 %id)
BQ645304 hepatocellular carcinoma, cell line, Liver .va 1 to 815 1 to 820 F108X N114K L115P N116H R118G ... tiling clone,   820/871
(94 %)
16 diff
(98.2 %id)
DW445080 Liver .vb-u 1 to 212 11 to 222   tiling clone,   212/223
(95 %)
5 diff
(97.8 %id)
BU662148 blood .vb-u 66 to 740 9 to 683 exact tiling clone,   675/683
(98 %)
6 diff
(99.2 %id)
BI225043 Burkitt lymphoma, lymph .vc 1 to 598 1 to 602 T98V C99D P100L L101P C102T ... tiling clone,   602/602
(100 %)
5 diff
(99.2 %id)
BE561357 Burkitt lymphoma, lymph .vc 21 to 780 1 to 764   tiling clone,   764/1136
(67 %)
16 diff
(98.6 %id)
BM463575 leiomyosarcoma, uterus .vd 1 to 923 1 to 928 E64K S71T K82S F83S P84R ... tiling clone,   928/988
(93 %)
22 diff
(97.8 %id)
BM838835 Ascites, stomach .ve 1 to 507 1 to 506 L94Q tiling clone,   506/506
(100 %)
2 diff
(99.7 %id)
DB243272 stomach, tumor tissue .vf 1 to 562 2 to 564 G5X N6Q A7C A8G A9C ... tiling clone, capped   563/563
(100 %)
3 diff
(99.5 %id)
BJ992630 hepatoblastoma .vg 1 to 497 5 to 501 exact     501/501
(100 %)
1 diff
(99.9 %id)
BP359372 mammary gland .vg 1 to 577 5 to 582 exact tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
CB128006 cervix, Uterine .vh 183 to 422 202 to 441 exact tiling clone,   441/441
(100 %)
1 diff
(99.8 %id)
BX647328 Liver .vi 1 to 2112 1 to 2112 exact tiling clone, available from DKFZ, AAA   2112/2112
(100 %)
0 diff
(100 %id)
CN419877 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vi 1242 to 1855 8 to 621       614/621
(98 %)
6 diff
(99.1 %id)
BE707697 head_neck .vi 1493 to 1637 157 to 13       145/157
(92 %)
1 diff
(99.4 %id)
AA452218   .vj 1 to 602 1 to 601 exact tiling clone,   601/601
(100 %)
1 diff
(99.9 %id)
BX279997 liver and spleen .vk-u 1 to 472 1 to 472 exact tiling clone,   472/472
(100 %)
2 diff
(99.6 %id)
T84682 liver and spleen .vk-u 1 to 289 1 to 295 S37F G38R S39A F40L C41S ...     295/321
(91 %)
20 diff
(93.8 %id)
T84265 liver and spleen .vk-u 2 to 325 1 to 329 H36S S37L G38R S39L C41L ...     329/401
(82 %)
7 diff
(98.3 %id)
T28287 colon, embryo .vl-u 1 to 309 1 to 315 exact tiling clone,   315/315
(100 %)
6 diff
(98.1 %id)
T90622 liver and spleen .vm-u 1 to 270 309 to 39 L6P V7S L8V S10I H11S ... tiling clone,   271/309
(87 %)
11 diff
(96.5 %id)
CR598526 B cells (Ramos cell line) Cot 25-normalized Gene HMBS, variant not shown         This clone was ignored    
CR606864 Neuroblastoma Cot 25-normalized Gene HMBS, variant not shown         This clone was ignored    
AL524270 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene HMBS, variant not shown       fully sequenced, This clone was ignored    
AL562330 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene HMBS, variant not shown       fully sequenced, This clone was ignored    
BX364100   Gene HMBS, variant not shown       fully sequenced, This clone was ignored    
BX364101   Gene HMBS, variant not shown       fully sequenced, This clone was ignored    
CV378720 placenta_normal Gene HMBS, variant not shown         Suspected internal deletion, this clone was ignored    
AI371375 2 pooled tumors (clear cell type), Kidney Gene HMBS, variant not shown         This clone was ignored    
AI307317 2 pooled tumors (clear cell type), Kidney Gene HMBS, variant not shown         This clone was ignored    
AI308187 2 pooled tumors (clear cell type), Kidney Gene HMBS, variant not shown         This clone was ignored    
BM988209 mixed Gene HMBS, variant not shown       AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
DB369860   Gene HMBS, variant not shown         This clone was ignored    
AU132868   Gene HMBS, variant not shown       capped This clone was ignored    
BU732465 eye, optic nerve Gene HMBS, variant not shown       AAA This clone was ignored    
BM684108 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene HMBS, variant not shown       fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
BM719751 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene HMBS, variant not shown       fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
BU624230 cell lines, Enchondroma Gene HMBS, variant not shown       AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
TI_151760451   Gene HMBS, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk-u, .vl-u, .vm-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI